Salapuddin, Mudzremar K.
HRN: 27-03-57 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/26/2025
CEFTRIAXONE 1G (VIAL)
04/26/2025
05/03/2025
IV
650mg
OD
T/C CNSI; PCAP
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: PneumoniaBloodstreamCentral Nervous SystemProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes